follow
commun
tripartit
synopsi
role
viral
infect
acquir
immunodefici
syndrom
aid
first
section
describ
impact
viral
opportunist
infect
aid
viru
clinic
present
diagnosi
laboratori
diagnost
approach
emphasi
electron
microscopi
therapeut
intervent
attempt
date
discuss
second
segment
explor
current
theori
pathogenesi
aid
describ
diagnost
therapeut
approach
syndrom
final
section
catalogu
ultrastructur
anomali
cell
aid
patient
mani
mistakenli
identifi
etiolog
agent
address
reprint
request
sara
e
miller
depart
microbiolog
immunolog
duke
univers
medic
center
durham
nc
alan
r
liss
inc
herp
zoster
viru
hzv
varicella
zoster
viru
vzv
caus
chickenpox
children
becom
latent
dorsal
root
spinal
gan
virus
occupi
uniqu
posit
pathogenesi
acquir
immunodefici
syndrom
aid
repres
primari
etiolog
agent
diseas
also
major
caus
associ
opportunist
infect
antivir
therapi
thu
central
import
palli
treatment
eventu
cure
aid
profound
defici
cellmedi
immun
typifi
aid
patient
virus
normal
elimin
kept
bay
immunocompet
host
becom
overwhelm
approach
era
therapi
viral
agent
commonplac
bacteria
agent
found
effect
viral
infect
precis
identif
caus
virus
becom
increasingli
essenti
sever
drug
proven
antivir
efficaci
patient
without
immunocompromis
use
success
individu
aid
though
perpetu
mainten
therapi
gener
requir
patient
prevent
recrudesc
viral
infect
improv
qualiti
prolong
life
attain
mani
instanc
reason
present
discuss
viru
diseas
seen
aid
patient
along
clinic
present
diagnosi
treatment
gener
method
viru
isol
laboratori
diagnosi
viral
diseas
describ
hsiung
malherb
stricklandcholmley
rothchild
cohen
white
fenner
detail
method
detect
identif
virus
electron
microscopi
em
publish
miller
doan
anderson
viru
concentr
procedur
identif
aidsrel
virus
describ
briefli
sever
virus
carri
aid
p
tient
includ
hepat
b
viru
hbv
human
immunodefici
viru
hlv
capabl
infect
immunocompet
individu
discuss
tissu
distribut
virus
extrem
divers
hiv
isol
bodili
fluid
number
site
well
leukocyt
therefor
sampl
suspect
aid
case
must
treat
extrem
care
glove
worn
routin
process
step
prior
fixat
specimen
process
biohazard
hood
possibl
quiet
corner
away
traffic
piec
plasticback
absorb
paper
extrem
care
must
taken
prevent
creation
aerosol
dispos
must
autoclav
discard
tool
contain
must
disinfect
easili
avail
disinfect
clorox
ethanol
fda
specimen
liquid
eg
cerebrospin
fluid
csf
blood
urin
stool
suspens
blister
fluid
tear
lavag
centrifug
low
speed
remov
cell
larg
debri
drop
sampl
place
parafilm
formvarand
carbonco
membran
grid
allow
sit
top
drop
min
grid
drain
filter
paper
transfer
drop
glutaraldehyd
phosphat
buffer
ph
min
wash
touch
three
drop
distil
water
drain
fixat
step
necessari
preserv
viru
structur
recommend
sampl
aid
patient
mean
kill
pathogen
virus
sinc
infecti
virion
surviv
neg
stain
absenc
fixat
step
grid
microscop
specimen
holder
must
properli
disinfect
view
neg
stain
accomplish
place
wash
drain
grid
onto
drop
aqueou
satur
uranyl
acet
phosphotungst
sec
drain
circumst
sampl
mix
neg
stain
atom
onto
grid
mani
sampl
contain
viru
high
enough
titer
allow
demonstr
simpl
fast
direct
method
describ
virus
present
lower
concentr
frequent
detect
util
one
liquid
sampl
concentr
techniqu
previous
describ
miller
briefli
lowspe
debri
clarif
viru
pellet
ultracentrifug
hr
ooog
airfug
ultracentrifug
beckman
instrument
fullerton
ca
lbhq
ooog
min
pellet
resuspend
remain
drop
decant
supernat
disinfect
drop
place
grid
describ
em
rotor
use
airfug
sampl
pellet
directli
onto
grid
lowspe
centrifug
ultrafiltr
devic
design
retain
particl
nm
greater
diamet
schleicher
schuell
keen
nh
altern
mean
concentr
viru
particl
specif
antibodi
pool
gamma
globulin
may
contain
virusreact
antibodi
ad
viru
suspens
clump
concentr
viru
particl
almeida
kapikian
et
al
final
antibodi
dilut
rang
incub
min
overnight
c
suspens
pellet
ooog
hr
pellet
resuspend
small
drop
remain
decant
supernat
place
grid
describ
pseudoreplica
techniqu
origin
describ
sharp
often
use
urin
suspect
contain
cytomegaloviru
cmv
drop
suspens
place
agar
block
liquid
allow
diffus
agar
formvar
solut
drop
onto
block
float
onto
water
surfac
pick
grid
similar
techniqu
place
grid
drop
suspens
agar
solut
diffus
agar
viru
concentr
onto
grid
anderson
doan
specif
antibodi
mix
agar
clump
virus
concentr
onto
grid
anderson
doan
util
specif
antibodi
addit
specimen
realiz
research
priori
idea
possibl
agent
present
specif
agent
suspect
pool
gamma
globulin
may
use
hope
contain
antibodi
virus
present
biopsi
ultrathin
section
process
routin
eg
glutaraldehyd
osmium
tetroxid
uranyl
acet
follow
embed
hayat
rapid
method
embed
less
hr
describ
miller
occasion
low
viru
concentr
preclud
visual
previous
discuss
techniqu
allow
round
two
viru
replic
tissu
cultur
amplifi
viral
number
level
detect
electron
microscop
miller
lang
appropri
cell
line
inocul
discuss
miller
one
must
keep
mind
virus
virus
grown
convent
tissu
cultur
cytomegaloviru
cmv
infect
often
asymptomat
normal
subject
sommervil
frequent
sever
aid
patient
quinnan
et
al
inde
literatur
viru
infect
individu
aid
pertain
cmv
postmortem
studi
show
patient
infect
viru
frequent
site
infect
lung
central
nervou
system
cn
retina
gastrointestin
go
tract
reticuloendotheli
system
kidney
adren
guarda
et
al
jensen
et
al
rodrigu
et
al
snider
et
al
tucker
et
al
viru
isol
blood
saliva
urin
semen
uterin
secret
breast
milk
csf
drew
et
al
edward
et
al
elmekki
et
al
quinnan
et
al
stagno
et
al
cmv
interstiti
pneumon
major
caus
morbid
mortal
aid
patient
frequent
cmv
pneumocysti
carinii
see
sun
teichberg
found
togeth
cmv
found
suspect
p
carinii
pneumonia
case
neg
protozoan
barbour
gorelkin
et
al
bronchoscop
lavag
success
establish
diagnosi
cmv
pneumon
case
golden
et
al
open
lung
biopsi
recommend
bronchoscopi
neg
barrio
et
al
unlik
herp
simplex
viru
hsv
herp
zoster
viru
hzv
cmv
neurotrop
ordinarili
caus
neurolog
diseas
immunocompet
individu
duchowni
et
al
immunocompromis
host
howev
caus
either
encephalomyel
demyelin
without
inflamm
central
peripher
nervou
system
moskowitz
et
al
tucker
et
al
mechan
demyelin
occur
unknown
possibl
includ
viral
cytotox
effect
support
cell
releas
lytic
factor
neighbor
cell
destroy
viru
autoimmun
attack
secondari
crossreact
viral
antigen
myelin
autosensit
damag
myelin
typic
lesion
includ
ventriin
aid
culiti
periventricular
destruct
cerebr
pituitari
involv
hawley
et
al
diffus
glial
nodul
enceph
snider
et
al
neurolog
symptom
includ
encephalopathi
often
progress
dementia
occasion
focal
motor
deficit
seizur
headach
fever
computer
tomographi
ct
head
may
unrev
case
inflamm
minim
contrast
ct
scan
potenti
valu
set
comparison
ct
find
differ
viral
cn
diseas
present
sanvar
et
al
magnet
reson
imag
mrd
studi
may
use
diagnosi
cmv
cn
infect
levi
et
al
post
et
al
howev
definit
diagnosi
rest
identif
viru
biopsi
materi
occasion
csf
often
autopsi
petito
et
al
tucker
et
al
cmv
major
caus
blind
aid
patient
palestin
et
al
cmv
retin
character
rapidli
progress
necrot
lesion
frequent
hemorrhag
obliter
retina
within
month
ophthalmoscop
examin
virusinduc
white
spot
granular
patch
difficult
distinguish
cotton
wool
spot
latter
occur
condit
ischemia
diabet
hypertens
anemia
repres
microinfarct
nerv
fiber
cmv
lesion
distinguish
rapidli
progress
natur
presenc
hemorrhag
rodrigu
et
al
demonstr
viru
tissu
globe
remov
autopsi
holland
jensen
et
al
pepos
et
al
hsv
toxoplasma
also
caus
retin
confus
diagnosi
neuwirth
et
al
color
ophthalmoscop
pictur
rosecan
et
al
de
venecia
et
al
demonstr
cmv
retin
lesion
cmv
retin
poor
prognost
sign
aid
usual
occur
late
cours
diseas
death
frequent
occur
within
week
follow
diag
nosi
retin
regardless
patient
medic
statu
onset
holland
cmv
caus
lesion
throughout
gi
tract
mouth
anu
aid
patient
alimentari
cmv
often
first
evid
aid
hinnant
et
al
manifest
includ
sever
debilit
diarrhea
mark
weight
loss
fever
stool
posit
occult
blood
occasion
massiv
colon
hemorrhag
perfor
frager
et
al
colonoscopi
may
show
yellow
maculopapular
lesion
levinson
bennett
radiograph
ct
find
specif
earli
lesion
may
show
frager
et
al
symptom
endoscop
colonoscop
radiograph
find
cmv
gi
diseas
mimic
ailment
includ
tumor
inflammatori
bowel
diseas
diffus
mucos
ulcer
granulomat
lesion
infecti
process
elta
et
al
frager
et
al
freedman
et
al
knapp
et
al
diagnosi
biopsi
must
made
rule
treatabl
condit
candidiasi
cmv
infect
adren
gland
caus
adren
insuffici
hypotens
bleiweiss
et
al
cmv
hepat
cholang
cholecyst
pancreat
describ
aid
patient
galloway
sack
freeman
agha
et
al
kavin
et
al
endocrin
problem
hypercalcemia
also
seen
result
cmv
infect
parathyroid
gland
zaloga
et
al
final
site
requir
comment
regard
cmvrelat
diseas
aid
patient
skin
primari
cutan
manifest
cmv
aid
propos
role
n
etiolog
agent
kaposi
sarcoma
ks
neoplasm
present
rais
reddishpurpl
lesion
skin
occasion
viscera
see
tucker
link
cmv
ks
circumstanti
strong
absenc
global
sever
immunosuppress
seen
latestag
aid
sever
studi
document
increas
titer
antibodi
cmv
epsteinbarn
viru
ebv
hsv
type
type
patient
ks
drew
giraldo
et
al
viru
isol
ks
tumor
biopsi
giraldo
et
al
cmv
dna
mrna
nuclear
antigen
demonstr
tumor
tissu
greenspan
shillito
fenoglio
et
al
cmv
known
oncogen
vitro
initi
cellular
dna
rna
protein
synthesi
genom
induc
transform
cultur
cell
giraldo
beth
rapp
viru
also
link
adenocarcinoma
colon
huang
roch
prostat
cancer
sanford
et
al
cervic
cancer
melnick
et
al
exact
role
cmv
ks
tumorigenesi
unclear
known
viru
act
directli
via
viral
onc
gene
product
recombin
alter
host
genom
provid
continu
immunosuppress
enabl
n
emerg
tumor
escap
surveil
spector
spector
argument
favor
cmv
etiolog
factor
ks
without
contradict
dotz
berman
describ
ks
patient
posit
antibodi
titer
hsv
absenc
anticmv
antibodi
hbv
demonstr
ks
tissu
well
cmv
siddiqui
howev
bulk
evid
accumul
date
suggest
cmv
play
part
etiolog
ks
cmv
report
sporad
caus
factor
nonneoplast
cutan
diseas
one
case
viru
demonstr
unusu
purpur
skin
lesion
patient
aid
penney
hick
author
report
stress
import
distinguish
lesion
papular
lesion
seen
poxviru
infect
see
numer
diagnost
modal
appli
detect
cmv
doerr
et
al
routin
serolog
analysi
circul
anticmv
antibodi
radioimmunoassay
ria
enzymelink
immunosorb
assay
elisa
griffith
kiefer
et
al
mckeat
et
al
nath
et
al
littl
valu
aid
patient
immunosuppress
patient
frequent
fail
mount
serolog
detect
antibodi
respons
cmv
doerr
et
al
convers
major
healthi
adult
possess
circul
igg
antibodi
cmv
though
appear
igm
anticmv
antibodi
may
correl
activ
viral
diseas
immunochem
detect
cmv
compon
use
success
ria
monoclon
antibodi
describ
detect
agent
goldstein
et
al
elisa
elmekki
et
al
mckeat
et
al
yolken
stopa
immunofiltr
techniqu
modifi
elisa
faster
simpler
almost
sensit
dna
hybrid
describ
rossier
et
al
techniqu
theoret
drawback
potenti
fail
detect
serolog
variant
viru
depend
heavili
sensit
specif
antibodi
employ
viral
cultur
use
detect
cmv
diagnost
techniqu
right
n
amplif
step
prior
em
miller
cultur
cmv
though
particularli
use
viru
present
low
concentr
disadvantag
extrem
timeconsum
detect
growth
may
requir
week
bach
doerr
et
al
tucker
et
al
detect
may
enhanc
lowspe
centrifug
special
tissu
cultur
vial
gleav
et
al
light
microscopi
lm
use
mean
detect
presenc
cmv
infect
addit
potenti
reveal
concomit
infect
organ
frequent
occurr
patient
aid
lm
nuclei
cmvinfect
cell
often
exhibit
owl
eye
morpholog
consist
dens
intranuclear
viral
inclus
surround
clear
halo
dens
margin
chromatin
nuclear
membran
knapp
et
al
nash
cytoplasm
inclus
may
also
present
intranuclear
inclus
best
demonstr
routin
hematoxylin
eosin
h
elstain
meiselman
et
al
papanicolaoustain
schulman
et
al
section
gomori
methenamin
silver
period
acidschiff
reaction
frequent
use
diagnosi
l
carinii
fungal
infect
stain
cytoplasm
intranuclear
cmv
inclus
thu
limit
valu
diagnosi
cmv
infect
gorelkin
et
al
excel
color
malherb
stricklandcholmley
black
white
hsiung
micrograph
cmvinfect
cell
publish
immunofluoresc
microscopi
use
demonstr
cmv
lung
lavag
specimen
emanuel
et
al
transbronchi
biopsi
blumenfeld
et
al
liver
tissu
sack
freeman
immunoperoxidas
stain
cmv
likewis
report
brain
spinal
cord
tissu
tucker
et
al
techniqu
though
rapid
hackman
et
al
carri
caveat
mention
connect
immunoassay
solubl
cmv
antigen
situ
hybrid
cmv
nucleic
acid
probe
also
proven
use
adjunct
diagnosi
cmv
infect
tissu
urin
specimen
technqu
capabl
detect
latent
infect
cell
chou
merigan
myerson
et
al
spector
spector
use
demonstr
cmv
colon
tissu
neg
viru
routin
histolog
immunofluoresc
examin
roch
et
al
hybrid
perform
formalinfix
paraffinembed
tissu
year
storag
myerson
et
al
em
use
consider
success
diagnosi
cmv
infect
tissu
bodili
fluid
especi
urin
em
examin
thin
section
spheric
nucleocapsid
nm
seen
mostli
nucleu
construct
fig
lc
nake
particl
may
escap
cytoplasm
obtain
outer
membran
nucleocapsid
receiv
outer
cover
bud
nuclear
membran
sometim
intern
membran
vesicl
sometim
cytoplasm
membran
whole
virion
may
nm
diamet
fig
la
b
nufioz
et
al
rodrigu
et
al
pliabl
nonorna
outer
cover
virion
may
difficult
distinguish
cellular
debri
neg
stain
unless
stain
penetr
membran
outlin
icosahedr
nucleocapsid
fig
ld
e
cmv
distinguish
em
member
herp
famili
therapi
cmv
infect
aid
patient
gener
unsatisfactori
greatest
experi
date
guanin
dhpg
acyclovir
analog
dhpg
also
known
various
bw
gancicyclovir
ganciclovir
bndg
use
success
treatment
cmv
pneumonia
collabor
dhpg
treatment
studi
group
laskin
et
al
cn
infect
retin
bach
humphrey
et
al
palestin
et
al
rosecan
et
al
though
aid
patient
experienc
prolong
surviv
improv
qualiti
life
result
therapi
kotler
et
al
discontinu
drug
invari
led
recrudesc
cmv
infect
dhpg
therapi
also
complic
bone
marrow
suppress
neutropenia
case
barbour
holland
et
al
phosphonoform
pfa
foscarnet
use
success
treatment
cmv
retin
may
requir
less
frequent
mainten
regimen
dhpg
singer
et
al
agent
acyclovir
acycloguanosin
zovirax
bach
vidarabin
adenin
arabinosid
araa
bach
cytarabin
cytosin
arabinosid
arac
alon
combin
interferon
furio
wordel
littl
therapeut
benefit
cmv
infect
alpha
interferon
use
treatment
ks
aid
patient
success
rate
appear
act
antineoplast
agent
rather
immun
modul
volberd
et
al
agent
use
report
success
includ
etoposid
vinblastin
combin
doxorubicin
bleomycin
vinblastin
krigel
herp
simplex
viru
hsv
type
caus
enceph
mening
myeliti
immunemedi
demyelin
britton
et
al
handler
perkin
heller
et
al
maier
et
al
nahmia
et
al
well
eye
pepos
et
al
skin
lesion
siegal
et
al
hsv
hepat
rare
occur
immunocompromis
patient
chase
et
al
hsv
enceph
hse
propens
involv
one
tempor
lobe
weiner
fleme
present
includ
fever
headach
stiff
neck
cloud
conscious
focal
neurolog
sign
includ
seizur
aphasia
focal
motor
sensori
deficit
mortal
hse
correl
level
conscious
initi
antivir
therapi
immunocompet
host
aid
patient
rapid
progress
diseas
proport
sever
degre
immun
suppress
hse
must
distinguish
diagnost
cryptococcosi
tuberculosi
bacteri
abscess
may
similar
clinic
present
hirsch
schooley
ct
electroencephalographi
eeg
may
suggest
tempor
lobe
lesion
radionuclid
scan
may
fig
lowermagnif
x
micrograph
virusinfect
cell
illustr
relationship
virus
cell
high
magnif
x
thin
section
neg
stain
virus
show
virion
ultrastructur
virus
print
magnif
permit
direct
comparison
size
micrograph
viruslik
structur
reproduc
present
final
magnif
comparison
magnif
select
closest
major
origin
micrograph
time
size
infect
cell
micrograph
size
virion
micrograph
high
magnif
complet
membran
virion
arrow
cytoplasm
c
high
magnif
nucleocapsid
arrow
nucleu
e
neg
stain
cmv
pleomorph
complet
particl
larg
arrowhead
nondescript
would
identifi
field
cell
membran
debri
nucleocapsid
small
arrowhead
lost
outer
cover
damag
stain
penetr
capsid
coat
e
membran
larg
arrowhead
still
surround
nuclsocapsid
small
arrowhead
broken
stain
penetr
outlin
nucleocapsid
bar
lpm
bar
nm
figur
ac
reprint
gorelkin
et
al
permiss
wb
saunder
co
provid
improv
detect
lesion
weiner
fleme
may
mri
schroth
et
al
presenc
tempor
lobe
involv
strongli
suggest
hse
one
studi
onehalf
seri
clinic
suspect
hse
case
eventu
shown
etiolog
nahmia
et
al
cmv
definit
diagnosi
requir
demonstr
viru
viral
antigen
biopsi
tissu
csf
aspir
hsv
retin
associ
enceph
contrast
cmv
retin
lesion
resembl
ischem
cotton
wool
spot
hsv
retin
character
retin
edema
hemorrhag
perivascul
advanc
stage
hazi
yellowwhit
necrot
retina
progress
exud
retin
detach
pepos
et
al
serolog
method
detect
activ
hsv
infect
describ
doerr
et
al
howev
case
cmv
limit
valu
aid
patient
sinc
major
healthi
individu
seroposit
hsv
immunosuppress
patient
hsv
infect
frequent
seroneg
lm
h
estain
section
hsvinfect
tissu
show
diffus
basophil
contract
eosinophil
intranuclear
inclus
sometim
margin
chromatin
malherb
stricklandcholmley
immunoperoxidas
stain
tissu
section
fix
bouin
fix
rather
formalin
also
use
demonstr
inclus
pepos
et
al
hsvand
cmvinfect
cell
frequent
similar
appear
though
latter
often
larger
inclus
occupi
greater
percentag
nucleu
unlik
cmv
hsv
caus
characterist
cytopatholog
effect
cpe
tissu
cultur
consist
shift
round
cellular
morpholog
follow
rapid
destruct
cell
monolay
within
day
hsiung
rapid
identif
techniqu
describ
make
use
centrifug
shell
vial
origin
describ
c
gleav
et
al
stain
fluorescein
monoclon
antibodi
detect
type
accomplish
day
winter
et
al
method
rapid
identif
hsv
describ
use
amplif
tissu
cultur
identif
em
miller
lang
electron
microscop
thin
section
fig
fig
resembl
cmv
fig
nucleocapsid
nm
may
seen
nucleu
cytoplasm
fig
b
complet
membran
virion
fig
seen
bud
nuclear
membran
cytoplasm
vesicl
cytoplasm
membran
fig
redund
membran
product
characterist
seen
herpesvirusinfect
cell
fig
tubular
structur
occasion
seen
within
nuclei
cell
infect
fig
fong
hsiung
neg
stain
blister
fluid
may
reveal
icosahedr
nucleocapsid
membran
broken
fig
though
gener
differenti
hzv
neg
stain
prepar
herpesvirus
poxviru
agent
molluscum
contagiosum
distinguish
readili
acyclovir
current
drug
choic
treatment
hsv
infect
hirsch
schooley
whitley
et
al
intraven
acyclovir
use
success
treatment
hse
immunocompet
patient
levi
et
al
also
use
manag
hsv
infect
patient
aid
barbour
intraven
vidarabin
decreas
mortal
hse
nonimmunocompromis
host
sinc
larg
volum
intraven
fluid
requir
vidarabin
administr
may
engend
brain
edema
brain
biopsi
recommend
establish
necess
treatment
furio
wordel
pepos
et
al
oral
acyclovir
may
prove
benefici
prophylaxi
hsv
infect
immunocompromis
host
fiddian
hirsch
schooley
topic
acyclovir
hsv
mucocutan
lesion
shorten
time
resolut
firstepisod
infect
less
effect
recurr
diseas
mindel
et
al
intraven
acyclovir
also
effect
seriou
skin
lesion
hirsch
schooley
ocular
hsv
kerat
treat
topic
trifluorothymidin
vidarabin
hirsch
schooley
nucleic
acid
analog
bromovinyldeoxyuridin
bvdu
chloroethyldeoxyuridin
cedu
fluoroiodoaracytosin
fiac
promis
new
topic
drug
herpet
kerat
de
clerq
neg
stain
virion
note
stain
penetr
membran
larg
arrowhead
allow
visual
capsom
petit
arrowhead
penetr
interior
nucleocapsid
compar
neg
stain
cmv
bar
pm
bar
bd
fig
one
intranuclear
nucleocapsid
filament
characterist
infect
bar
nm
reprint
fong
hsiung
permiss
crc
press
inc
glia
may
reactiv
later
reactiv
often
take
form
shingl
pain
vesicular
skin
rash
result
defici
cell
killer
cell
activ
frequent
seen
elderli
patient
shingl
may
accompani
neurolog
complic
includ
postherpet
neuralgia
paresi
meningoenceph
immunocompromis
patient
dissemin
hzv
infect
may
occur
gi
pulmonari
nervou
system
involv
friedmankien
et
al
hzv
cn
infect
individu
aid
may
take
form
hemorrhag
necrot
enceph
earli
symptom
headach
fever
seizur
aphasia
hzv
also
caus
shingl
aid
patient
may
earli
clinic
indic
impend
aid
risk
cone
schiffman
payn
et
al
friedmankien
et
al
hzv
infect
eye
young
adult
marker
aid
cole
et
al
levi
et
al
sandor
et
al
hzv
also
report
biopsi
hairi
leukoplakia
hl
lesion
isol
lung
tissu
without
histolog
evid
pulmonari
infect
ryder
et
al
laboratori
diagnost
approach
hzv
infect
similar
util
herpesviru
infect
includ
cultur
lm
without
immunoperoxidas
stain
southern
blot
hybrid
em
doerr
et
al
gilden
et
al
ryder
et
al
lm
examin
may
reveal
intranuclear
cytoplasm
inclus
difficult
distinguish
seen
hsv
infect
hsiung
malherb
stricklandcholmley
immunostain
may
aid
differenti
em
typic
herp
famili
nucleocapsid
membran
virion
evid
thin
section
hzv
neg
stain
resembl
hsv
distinguish
poxviru
differenti
hzv
herpet
infect
import
select
proper
drug
therapi
dhpg
activ
cmv
infect
affect
hzv
higher
concentr
acyclovir
requir
hzv
hsv
infect
murray
intraven
vidarabin
acyclovir
fiac
use
treatment
hzv
infect
agent
decreas
cutan
spread
acceler
pain
resolut
may
prevent
fatal
dissemin
particularli
therapi
initi
within
hour
appear
cutan
lesion
chang
et
al
efficaci
acyclovir
reportedli
greater
vidarabin
furio
wordel
shepp
et
al
addit
therapeut
approach
current
studi
includ
oral
acyclovir
intramuscular
vidarabin
wood
et
al
sherlock
corey
new
drug
includ
bvdu
de
clercq
immunocompet
patient
prednison
decreas
sever
pain
hsvinduc
lesion
reduc
likelihood
postherpet
neuralgia
howev
corticosteroid
may
induc
dissemin
hzv
thu
contraind
immunocompromis
patient
murray
corticosteroid
may
also
predispos
dissemin
cmv
infect
aid
patient
armstrong
et
al
gold
epsteinbarr
viru
ebv
implic
etiolog
agent
burkitt
lymphoma
b
cell
lymphoma
african
epstein
achong
purtilo
et
al
orient
ebv
associ
nasopharyng
carcinoma
klein
american
european
primari
clinic
import
caus
agent
infecti
mononucleosi
henl
et
al
howev
burkittslik
lymphoma
report
aid
patient
see
tucker
ebv
demonstr
lymphoma
berman
et
al
rosenberg
et
al
whangpeng
et
al
chromosom
transloc
similar
burkitt
lymphoma
demonstr
aid
b
cell
lymphoma
gyger
et
al
lipscomb
et
al
lipscomb
et
al
petersen
et
al
whangpeng
et
al
possibl
factor
predispos
patient
aid
ebvrel
malign
includ
profound
cell
immunodefici
abnorm
high
number
ebvinfect
b
cell
birx
et
al
purtilo
et
al
sumaya
et
al
addit
posit
etiolog
role
b
cell
lymphoma
ebv
link
circumstanti
sever
condit
aid
patient
ebv
antigen
demonstr
oral
neoplasm
includ
squamou
cell
carcinoma
oral
ks
greenspan
shillito
ziegler
et
al
viru
found
lung
patient
lymphocyt
interstiti
pneumonia
brain
children
aid
andiman
et
al
biopsi
oral
hl
condit
manifest
white
flatten
plaqu
side
ventral
surfac
tongu
role
ebv
pathogenesi
hl
unclear
immunoperoxidas
stain
tissu
hl
plaqu
also
shown
mani
case
contain
papillomaviru
case
hsv
greenspan
et
al
cours
hl
variabl
may
spontan
regress
recurr
known
lesion
premalign
condit
sinc
herpesvirus
papillomavirus
implic
possibl
caus
agent
sinc
oncogen
capabl
regular
observ
biopsi
recommend
young
et
al
hl
must
distinguish
clinic
oral
candidiasi
may
respond
favor
antifung
therapi
morpholog
biochem
identif
ebv
contrast
member
herp
famili
play
rel
minor
role
clinic
diagnosi
ebvrel
complic
aid
diagnosi
b
cell
lymphoma
reli
mainli
histolog
immunohistochemistri
occasion
cytogenet
similarli
presenc
hl
gener
confirm
histolog
lm
lesion
resembl
flat
wart
superfici
whorl
fine
keratin
respons
hairi
appear
ebv
serolog
suffer
drawback
serolog
analysi
herpesvirida
hightit
antiebv
antibodi
present
mani
healthi
individu
pregnant
women
approxim
onehalf
normal
individu
test
exhibit
degre
seroposit
presum
result
latent
viral
infect
antiebv
antibodi
also
frequent
found
recipi
organ
transplant
patient
lymphoprolif
diseas
contrast
virusposit
individu
produc
serolog
respons
fackler
et
al
almost
aid
patient
exhibit
elev
antiebv
titer
ciobanu
wiernik
rinaldo
et
al
suggest
mani
may
harbor
infect
due
viral
reactiv
facilit
immunosuppress
certain
ebv
antigen
detect
immunohistolog
analysi
viral
capsid
antigen
vca
present
viral
replic
epsteinbarr
nuclear
antigen
ebna
also
detect
latent
infect
cell
lindahl
et
al
pearson
et
al
nucleic
acid
hybrid
also
use
detect
presenc
ebv
genom
product
latent
infect
cell
andiman
et
al
brandsma
miller
pi
et
al
em
cell
product
infect
ebv
reveal
viru
particl
morpholog
similar
herpesvirus
viru
particl
demonstr
em
lesion
hl
em
routin
use
diagnost
procedur
disord
ebv
morpholog
virusinduc
cpe
describ
epstein
achong
vitro
activ
replic
ebv
sensit
sever
antivir
agent
includ
vidarabin
phosphonoacet
acid
acyclovir
drug
effect
latent
infect
cell
acyclovir
use
success
treatment
polyclon
b
cell
lymphoma
monoclon
b
cell
lymphoma
often
develop
subsequ
andersson
et
al
hirsch
schooley
hepat
b
viru
hbv
widespread
among
homosexu
men
intraven
drug
abus
patient
aid
latter
gener
seroposit
viru
spite
fact
clinic
overt
liver
diseas
unusu
aid
patient
find
keep
current
concept
antivir
cellular
immun
respons
play
major
role
pathogenesi
hbv
hepat
ray
et
al
rustigi
et
al
hepatocellular
carcinoma
link
clinic
rometlemonn
et
al
experiment
griffith
hbv
infect
likewis
seen
increas
frequenc
aid
patient
hbv
infect
gener
diagnos
serolog
detect
circul
viral
antigen
antivir
antibodi
omata
et
al
barr
mitchel
hoar
et
al
viru
also
detect
nucleic
acid
hybrid
techniqu
rometlemonn
et
al
scotto
et
al
siddiqui
yoff
et
al
sometim
absenc
detect
hbv
antibodi
antigen
hoar
et
al
laur
et
al
routin
histolog
analysi
use
clinic
assess
hepat
acut
chronic
phase
though
mani
histolog
find
hbv
hepat
indistinguish
encount
hepat
caus
virus
drug
toxin
huang
fisher
histolog
examin
augment
immunofluoresc
analysi
hepat
b
surfac
antigen
hbsag
hepat
b
core
antigen
hbcag
ray
et
al
hbv
grown
convent
tissu
cultur
howev
level
viremia
often
attain
acut
infect
particlesml
griffith
permit
demonstr
em
particularli
ultracentrifug
immunoaggreg
see
materi
method
infecti
viru
dane
particl
measur
nm
diamet
roughli
spheric
frequent
accompani
noninfecti
spheric
filament
particl
compos
viral
capsid
antigen
hbsag
fig
liver
tissu
aggreg
nondescript
intracytoplasm
particl
seen
fig
b
sever
antivir
agent
includ
vidarabin
acyclovir
human
leukocyt
interferon
employ
variabl
success
treatment
hbv
infect
respons
rate
rang
neglig
high
report
vidarabin
interferon
studi
involv
immunocompet
patient
thoma
et
al
papovavirus
associ
progress
multifoc
leukoencephalopathi
pml
subacut
demyelin
diseas
seen
patient
lymphoprolif
chronic
granulomat
immunosuppress
disord
symptom
diseas
includ
blur
vision
blind
numb
dizzi
hemiparesi
ataxia
levi
et
al
affect
individu
gener
afebril
two
relat
papovavirus
implic
etiolog
pml
j
c
viru
jcv
found
case
studi
date
simian
papovaviru
isol
small
number
case
zu
rhein
coleman
et
al
narayan
et
al
jcv
bk
viru
bkv
third
papovaviru
whose
etiolog
role
pml
firmli
establish
like
jcv
deriv
name
initi
patient
first
isol
frequent
shed
urin
transplant
patient
andrew
et
al
hogan
et
al
urin
late
pregnanc
puerperium
coleman
et
al
major
healthi
individu
expos
virus
adolesc
fig
hbcag
particl
cytoplasm
n
infect
hepat
cell
b
complet
hbv
virion
arrowhead
cytoplasm
n
infect
cell
c
neg
stain
show
infect
dane
particl
arrowhead
hbsag
tubular
pleomorph
spheric
form
bar
nm
reprint
huang
fisher
permiss
william
wilkin
co
pathogenesi
pml
incomplet
understood
ubiqu
associ
papovavirus
normal
individu
suggest
diseas
may
repres
reactiv
latent
infect
rather
primari
infect
krupp
et
al
chester
et
al
pml
occur
frequent
aid
patient
develop
diseas
individu
immunosuppress
disord
propos
hiv
brain
may
direct
effect
reactiv
latent
papovavirus
stoner
et
al
ct
scan
lesion
pml
appear
hypodens
area
white
matter
cortic
spare
frequent
origin
one
cerebr
hemispher
often
local
occipit
lobe
subsequ
spread
involv
remaind
brain
presenc
lesion
set
normal
csf
examin
diagnost
pml
similar
ct
find
occasion
encount
toxoplasmosi
cerebr
infect
toxoplasma
invari
associ
csf
perturb
weiner
fleme
case
diagnosi
uncertain
ctdirect
needl
biopsi
provid
tissu
virolog
examin
snider
et
al
papovaviru
infect
detect
number
techniqu
serolog
use
sinc
adult
antibodi
jcv
patient
pml
increas
titer
normal
individu
brook
walker
padgett
walker
howev
bkv
jcv
detect
nucleic
acid
hybrid
renal
tissu
pml
patient
chester
et
al
jcv
fastidi
isol
primari
human
fetal
glial
cell
urinederiv
epitheli
cell
bkv
less
restrict
host
cell
beckman
shah
spite
avail
techniqu
diagnosi
pml
gener
requir
examin
involv
brain
tissu
advanc
lesion
necrot
center
contain
numer
foami
phagocyt
cell
peripheri
lesion
enlarg
deform
astrocyt
resembl
malign
cell
found
glial
cell
intranuclear
viral
inclus
may
seen
detail
descript
histopatholog
pml
provid
richardson
et
al
mckeever
et
al
fluoresc
microscopi
use
detect
papovaviru
antigen
brain
tissu
budka
shah
immunohistolog
pml
somewhat
complex
infect
tissu
often
reactiv
antisera
jcv
narayan
et
al
howev
antibodi
antigen
also
stain
nuclei
jcvinfect
cell
occasion
absenc
stain
viral
antigen
oligodendrocyt
astrocyt
appear
infect
stoner
et
al
antigen
destroy
formaldehyd
fixat
though
viru
stabl
antigen
preserv
acetonefix
frozen
section
em
pml
agent
spheric
virus
frequent
associ
filament
nm
diamet
fig
c
zu
rhein
neg
stain
urin
specimen
virus
appear
icosahedra
fig
e
treatment
pml
attempt
vidarabin
cytarabin
initi
improv
unsatisfactori
aid
patient
krupp
et
al
peter
et
al
snider
et
al
walker
human
papillomavirus
hpv
caus
condyloma
acuminatum
vener
wart
highli
infecti
sexual
transmit
diseas
ferenczi
et
al
associ
malign
transform
bank
et
al
gupta
et
al
mccanc
strain
may
give
rise
dysplasia
without
wart
frazer
et
al
perian
condylomata
common
homosexu
anorect
carcinoma
report
aid
patient
croxson
et
al
frazer
et
al
along
virus
herp
famili
hpv
report
lesion
oral
hl
see
epsteinbanviru
greenspan
et
al
se
mller
dn
howel
fig
hpv
nucleu
n
infect
cell
small
nondescript
particl
occasion
align
crystallin
array
b
high
magnif
nondescript
nuclear
particl
c
neg
stain
bovin
papillomaviru
virion
appear
knobbi
warti
note
similar
jcv
bkv
bar
bar
b
viru
compon
detect
immunolabel
bank
et
al
situ
hybrid
gupta
et
al
wickenden
et
al
howev
diagnosi
usual
made
routin
histolog
excis
lesion
histolog
characterist
wart
includ
epiderm
hyperplasia
hyperkerato
si
cytoplasm
vacuol
eosinophil
inclus
excess
nuclear
basophilia
murphi
et
al
papillomavirus
detect
em
though
gener
use
clinic
diagnosi
wart
em
neg
stain
wart
virus
show
knobbi
icosah
ron
fig
thin
section
viru
appear
nuclei
cell
dens
spheric
particl
sometim
crystallin
array
fig
b
nuclear
viru
particl
must
differenti
nuclear
granul
nonspecif
clump
chromatin
result
cell
injuri
fig
virus
uniform
size
distinct
round
shape
nuclear
granul
uniformli
size
shape
ultrastructur
wart
inclus
bodi
describ
almeida
lm
em
malign
lesion
describ
kovi
et
al
howev
nuclear
densiti
describ
question
viral
natur
wart
caus
papillomaviru
differenti
carcinomalik
buschkelowenstein
tumor
latter
respons
podophyllin
kovi
et
al
potenti
malign
vener
wart
remov
achiev
topic
treatment
podophyllin
benzoin
cancer
treatment
must
direct
tumor
rather
viru
includ
surgeri
radiat
kovi
et
al
adenovirus
caus
number
respiratori
ill
conjunct
immunocompet
patient
also
found
individu
without
evid
diseas
taylor
usual
seen
urin
healthi
individu
chonvitz
et
al
adenovirus
isol
patient
aid
gotlieb
et
al
honvitz
et
al
siegal
et
al
one
case
enceph
aid
patient
dementia
spastic
quadriparesi
adenoviru
isol
csf
horoupian
et
al
causal
relationship
viru
brain
degener
unknown
viru
isol
urin
aid
patient
de
jong
et
al
also
isol
stool
armstrong
et
al
signific
adenoviru
infect
diseas
immunodefici
aid
known
strain
suggest
cofactor
syndrom
horwitz
et
al
mani
human
adenoviru
strain
common
infect
earli
life
frequent
hierholz
et
al
de
jong
et
al
make
serolog
use
diagnosi
cultur
isol
difficult
urin
provid
hostil
environ
viru
surviv
strain
isol
locat
certain
strain
difficult
cultur
circumst
hybrid
techniqu
horwitz
et
al
engler
kilpatrick
em
use
detect
viru
lm
inclus
nuclei
infect
cell
stain
dens
malherb
stricklandcholmley
adenovirusinfect
cell
cultur
exhibit
cpe
consist
cellular
round
clump
hsiung
em
viru
nake
icosahedron
triangular
facet
resembl
geodes
dome
often
seen
neg
stain
fig
thin
section
flat
facet
side
sometim
align
creat
crystallin
array
dna
viru
adenoviru
found
nucleu
fig
c
treatment
describ
adenoviru
infect
poxviru
caus
molluscum
contagiosum
sexual
transmit
papular
skin
lesion
immunocompet
individu
usual
selflimit
resolv
spontan
month
aid
patient
diseas
extens
often
occur
face
redfeld
et
al
absenc
exogen
immunosuppress
extens
molluscum
lesion
unusu
locat
unusu
rapid
recurr
despit
dilig
therapi
suggest
aid
katzman
et
al
lombardo
sarma
weilbaech
diseas
must
differenti
cutan
cryptococcosi
hypopig
papul
rico
pen
ney
cutan
cmv
infect
penney
hick
characterist
histolog
includ
epitheli
hyperplasia
downward
lobular
growth
epiderm
cell
molluscum
bodi
stratum
granulosum
stratum
cortiv
stain
prepar
agent
larg
brickshap
viru
measur
nm
nm
nm
repres
poxviru
shown
figur
neum
larg
homogen
cytoplasm
contain
viru
katzman
et
h
estain
section
molluseum
bodi
within
deeper
epitheli
strata
eosinophil
superfici
cell
basophil
cpe
poxvirusinfect
cell
cultur
includ
multinucl
cell
hsiung
em
negaeasili
distinguish
spheric
herpesvirus
fact
potenti
valu
differenti
molluscum
lesion
hsv
blister
lesion
shingl
thin
section
poxviru
appear
cytoplasm
cell
larg
oval
bodi
dens
coat
fig
matur
particl
condens
core
shape
dumbbel
fig
e
neg
stain
show
rough
brickshap
virion
fig
treatment
molluscum
contagiosum
curettag
cryotherapi
lesion
drug
treatment
present
avail
though
acycl
carbocycl
adenosin
analogu
neoplanocin
shown
promis
poxviru
well
virus
de
clercq
coronavirus
seen
associ
enter
infect
macnaughton
chani
et
al
vaucher
et
al
also
demonstr
appar
healthi
individu
maass
baumeist
strain
associ
cold
symptom
mcintosh
larson
et
al
coronaviru
particl
demonstr
stool
sampl
aid
patient
serum
one
patient
lymphadenopathi
syndrom
la
diarrhea
seen
healthi
homosexu
male
seen
healthi
heterosexu
kern
et
al
although
coronavirus
associ
diseas
normal
individu
aid
patient
appear
major
contributor
morbid
mortal
either
group
elisa
describ
detect
coronaviru
macnaughton
neg
stain
em
coronavirus
membran
pleomorph
particl
stud
clublik
spike
fig
nucleocapsid
nondescript
thin
section
virion
seen
within
bud
cisterna
endoplasm
reticulum
fig
b
becker
et
al
treatment
describ
coronaviru
infect
parvoviru
noncultiv
picornaor
parvoviruslik
ncpp
particl
seen
children
aid
detect
hybrid
serolog
wainberg
mill
howev
role
aid
suggest
agent
anderson
et
al
human
tlymphotrop
viru
type
htlvi
lymphotrop
retroviru
caus
malign
transform
rather
deplet
helper
cell
etiolog
agent
form
cell
leukemia
endem
portion
japan
caribbean
frequent
encount
elsewher
catovski
et
al
hayn
et
al
poiesz
et
al
tajima
et
al
htlvi
isol
sever
aid
patient
getchel
et
al
harper
et
al
kanner
et
al
palmer
et
al
gallo
suggest
viru
may
advanc
progress
aid
edward
morpholog
htlvi
describ
palmer
goldsmith
pp
shamoto
et
al
sinc
initi
descript
human
immunodefici
viru
hiv
establish
necessari
factor
pathogenesi
aid
montagni
et
al
montagni
sarngadharan
et
al
central
etiolog
role
hiv
notwithstand
numer
question
remain
regard
potenti
contribut
factor
develop
diseas
chief
among
follow
addit
extern
influenc
particularli
viral
infect
necessari
prior
subsequ
exposur
hiv
develop
aid
genet
factor
viru
host
influenc
suscept
aid
individu
infect
hiv
subsequ
develop
overt
aid
elimin
viru
maintain
perpetu
equilibrium
similar
seen
herpesvirus
addit
hiv
numer
exogen
factor
suggest
necessari
least
conduc
develop
aid
sever
mode
action
propos
cofactor
includ
induct
activ
lymphocyt
primari
target
cell
h
n
infect
montagni
et
al
facilit
hiv
infect
via
immunosuppress
reactiv
latent
hiv
infect
evid
cofactor
etiolog
aid
deriv
larg
epidemiolog
vitro
studi
firm
establish
etiolog
role
given
factor
hamper
lack
suitabl
anim
model
aid
chim
panze
infect
hiv
make
antibodi
viru
fail
develop
subsequ
immunodefici
numer
studi
implic
hbv
cofactor
aid
patient
aid
serolog
posit
hbv
elfassi
et
al
rustigi
et
al
noonan
et
al
hbv
infect
similar
newli
diagnos
aid
victim
frequent
possess
hightit
antibodi
hbcag
hbsag
suggest
hbv
infect
anted
develop
aid
hbv
lymphotrop
hbv
dna
demonstr
peripher
blood
cell
bone
marrow
numer
patient
rometlemonn
et
al
elfassi
et
al
yoff
et
al
includ
patient
aid
laur
et
al
lieinjo
et
al
noonan
et
al
inde
peripher
blood
mononuclear
cell
aid
patient
contain
hbv
dna
frequent
hepat
patient
without
aid
though
known
whether
fact
reflect
predisposit
aid
individu
infect
hbv
n
increas
suscept
hbv
infect
individu
aid
homosexu
highrisk
group
aid
expos
cmv
ebv
hsv
agent
likewis
propos
possibl
aid
cofactor
cmv
infect
caus
extend
immunosuppress
frequent
associ
lower
helperhuppressor
cell
ratio
giraldo
beth
rapp
schechter
et
al
addit
possibl
etiolog
role
aid
drew
cmv
strongli
implic
cofactor
kaposi
sarcoma
see
ebv
report
decreas
helper
suppressor
cell
ratio
schechter
et
al
well
cell
cytotox
ebvinfect
target
cell
ragona
et
al
role
ebv
aidsrel
complex
arc
propos
ragona
et
al
rinaldo
et
al
schechter
et
al
symptom
arc
includ
anorexia
malais
fatigu
night
sweat
frequent
resolv
parallel
declin
antiebv
antibodi
titer
gervai
et
al
gervai
et
al
ebv
also
potent
transform
agent
implic
possibl
etiolog
factor
sever
malign
see
hsv
jcv
dna
virus
shown
augment
hiv
gene
express
vitro
mosca
et
al
dispar
natur
virus
led
specul
common
induct
effect
hiv
may
mediat
indirectli
via
host
cellular
mechan
spite
observ
role
virus
hiv
cofactor
aid
mean
firmli
establish
epidemiolog
evid
particular
complex
occasion
contradictori
cmv
hsv
though
commonli
encount
patient
sexual
acquir
aid
less
preval
hemophiliac
children
contract
diseas
hematogen
exposur
hiv
uncommon
tropic
area
aid
nonetheless
endem
blaser
cohn
propon
viral
cofactor
theori
counter
mani
hemophiliac
serolog
evid
exposur
herpesvirus
hbv
landay
et
al
sullivan
et
al
other
factor
viii
inject
may
immunosuppress
properti
provid
n
altern
predisposit
hiv
infect
verani
et
al
hivseroposit
hemophiliac
includ
high
antihiv
antibodi
titer
volski
et
al
may
inde
lower
frequenc
overt
aid
seroposit
homosexu
men
sullivan
et
al
likewis
mani
children
aid
includ
infant
evid
ebv
infect
rubinstein
scott
et
al
immunolog
immatur
neonat
could
conceiv
provid
n
altern
viral
cofactor
facilit
hiv
infect
rubinstein
inabl
immun
system
childhood
mount
full
respons
hiv
infect
illustr
observ
asymptomat
children
harbor
hiv
lack
serolog
detect
antihiv
antibodi
borkowski
et
al
pahwa
et
al
seroposit
infant
arc
lose
antibodi
respons
hiv
age
month
mok
et
al
exogen
factor
initi
suggest
cofactor
aid
illicit
drug
use
increas
number
male
sexual
partner
frequent
recept
anal
intercours
seem
direct
role
pathogenesi
diseas
factor
appear
oper
increas
probabl
exposur
hiv
schechter
et
al
develop
overt
aid
may
function
geneticsboth
infect
hiv
strain
human
host
sever
aidscaus
virus
consider
genet
virul
variat
isol
barin
et
al
coffin
edward
ratner
et
al
shaw
relationship
clinic
sever
hiv
infect
vitro
replic
potenti
viru
demonstr
asjo
et
al
differ
type
hiv
vari
respect
growth
rate
sever
cytopatholog
effect
cpe
report
riibsamenwaigmann
et
al
two
hiv
variant
differ
dna
restrict
map
seen
one
patient
suggest
either
antigen
variat
superinfect
one
two
strain
sodroski
et
al
suggest
mechan
regul
latent
lytic
phase
viru
life
cycl
see
review
hiv
genet
contribut
em
knowledg
regard
host
genet
suscept
one
studi
suggest
individu
lymphocyt
suppress
hiv
activ
walker
et
al
genet
studi
aid
patient
ks
shown
increas
histocompat
antigen
decreas
giraldo
et
al
also
specul
hiv
adher
lymphocyt
via
molecul
induc
product
antibodi
crossreact
endogen
ligand
thu
interf
lymphocyt
commun
necessari
normal
immun
respons
stricker
et
al
ziegler
et
al
yet
unclear
whether
hiv
infect
occasion
compat
surviv
normal
life
span
invari
lead
prematur
demis
factor
delimit
hivposit
asymptomat
individu
victim
overt
aid
clearli
identifi
vall
et
al
though
wide
variat
health
statu
hivseroposit
individu
suggest
may
capabl
exist
equlibrium
agent
estim
approxim
individu
infect
hiv
develop
aid
within
year
statist
unavail
develop
aid
follow
longer
latenc
estim
rang
high
greater
gonda
person
commun
addit
etiolog
role
immunodefici
hiv
capabl
directli
infect
cn
neurolog
hiv
diseas
may
preced
immunodefici
estim
occur
aid
victim
berger
de
la
mont
et
al
purtilo
et
al
initi
manifest
includ
acut
chronic
mening
enceph
dementia
myelopathi
peripher
neuropathi
encephalopathi
common
hivassoci
neurolog
disord
earli
symptom
subtl
includ
mild
progress
memori
loss
gener
weak
motor
disturb
occasion
seizur
berger
present
hiv
encephalopathi
frequent
similar
opportunist
encephalitid
hsv
cmv
enceph
pml
cn
toxoplasmosi
sinc
disord
potenti
treatabl
everi
effort
made
establish
definit
diagnosi
mri
noninvas
studi
choic
csf
examin
viru
antivir
antibodi
altern
present
hiv
cn
diseas
seen
less
frequent
hiv
asept
mening
occasion
encount
sometim
associ
mononucleosislik
syndrom
peripher
neuropathi
may
also
occur
manifest
includ
motor
disturb
resembl
guillainbarr
syndrom
pain
weak
autonom
neuropathi
csf
gener
normal
hiv
peripher
neuropathi
associ
myopathi
uncertain
etiolog
weak
electromyograph
abnorm
occasion
seen
berger
current
center
diseas
control
surveil
case
definit
aid
reli
partial
though
mean
exclus
presenc
laboratori
evid
hiv
infect
center
diseas
control
number
laboratori
procedur
detect
hiv
proven
use
diagnosi
aid
howev
number
addit
laboratori
diagnost
procedur
may
use
confirm
presenc
aid
detect
hivassoci
cn
infect
mani
test
avail
detect
antibodi
hiv
sever
elisa
commerci
avail
rel
simpl
perform
sensit
better
specif
rang
gurtler
et
al
sarngadharan
et
al
weiss
et
al
western
blot
analysi
gener
use
confirm
presenc
antihiv
antibodi
though
labor
intens
routin
serolog
test
towbin
et
al
western
blot
test
gener
correl
presenc
viru
antibodi
titer
correl
progress
aid
casareal
et
al
casareal
et
al
howev
valu
serolog
test
hiv
decreas
somewhat
fact
virusposit
individu
antibodi
neg
mani
present
healthi
individu
known
antihiv
antibodi
salahuddin
et
al
biochem
assay
detect
presenc
hiv
identifi
specif
viral
enzym
revers
transcriptas
rt
seen
uninfect
cell
poiesz
et
al
assay
provir
dna
also
avail
gelmann
et
al
detect
system
viral
compon
includ
dotblot
hybrid
antigen
captur
radioimmunoassay
monro
et
al
gupta
et
al
viru
isol
peripher
blood
cell
activ
cocultiv
suscept
cell
levi
et
al
popov
et
al
isol
csf
ho
et
al
lm
hivinfect
brain
tissu
show
multinucl
giant
cell
foami
macrophag
necrosi
perivascular
inflamm
demyelin
may
also
present
berger
de
la
mont
et
al
immunoperoxidas
stain
show
viral
antigen
mani
differ
cell
type
ward
et
al
lm
also
use
demonstr
cpe
hiv
leukocyt
cultur
rubsamenwaigmann
et
al
hiv
seen
routin
em
lymphocyt
patient
aid
unless
first
activ
cocultiv
suscept
tissu
cultur
cell
stimul
growth
factor
montagni
et
al
viru
seen
directli
em
brain
biopsi
oligodendroglia
astroglia
macrophag
macrophagelik
multinucl
cell
well
extracellular
space
capillari
lumen
endotheli
gap
epstein
et
al
epstein
et
al
gyorkey
et
al
koenig
et
al
wiley
et
al
seen
germin
center
lymph
node
hammar
et
al
warner
et
al
em
techniqu
use
detect
hiv
includ
examin
thin
section
infect
tissu
scan
electron
microscopi
infect
cell
neg
stain
purifi
viru
tsuchi
et
al
well
immunogold
label
hivinfect
cell
cultur
pekov
et
al
electron
microscop
morpholog
viru
discuss
detail
schupbach
et
al
treatment
aid
attempt
number
antivir
agent
inde
aid
epidem
done
much
spur
rapid
develop
drug
therapi
aid
opportunist
complic
sever
drug
shown
vitro
activ
hiv
clinic
efficaci
variabl
azidothymidin
azt
inhibit
hiv
replic
cpe
drug
current
market
aid
molecular
mechan
action
azt
describ
yarchoan
broder
side
effect
headach
neutropenia
anemia
acyclovir
antiherpet
agent
potenti
antiretrovir
action
azt
mechan
potenti
unknown
yarchoan
broder
suramin
germanin
human
use
alreadi
trypanosomiasi
onchocerciasi
inhibit
hiv
vitro
howev
efficaci
vivo
equivoc
use
associ
high
incid
adren
insuffici
rash
fever
liver
toxic
fda
tuazon
labriola
ribavirin
use
success
treatment
rna
viru
infect
includ
influenza
show
vitro
activ
hiv
vivo
decreas
viral
rt
activ
lymphocyt
elimin
viru
revers
side
effect
includ
anemia
nausea
headach
mental
statu
chang
humal
trial
continu
fda
tuazon
labriola
antimoniotungst
activ
vivo
anim
broad
rang
rna
dna
virus
inhibit
rt
hiv
initi
studi
show
viru
elimin
patient
reappear
viremia
discontinu
drug
patient
clinic
improv
thrombocytopenia
liver
dysfunct
fever
side
effect
clinic
trial
progress
fda
tuazon
labriola
phosphonoform
inhibit
dna
polymeras
human
herpesvirus
use
topic
treatment
cmv
retin
herp
mucocutan
lesion
also
inhibit
rt
retrovirus
clinic
trial
aid
arc
patient
underway
denmark
sweden
main
side
effect
phosphoform
kidney
toxic
fda
tuazon
labriola
dhpg
effect
cmv
also
vitro
activ
hiv
clinic
trial
ansamycin
sever
drug
vitro
activ
hiv
prepar
clinic
trial
fda
de
clercq
avenu
potenti
therapeut
strategi
includ
passiv
treatment
immun
globulin
reconstitut
immun
system
bone
marrow
transplant
lymphocyt
transfus
enhanc
immun
system
immunomodul
includ
endogen
substanc
cy
interferon
thymosin
transfer
factor
exogen
agent
ampligen
inosin
pranobex
isoprinosin
imuthiol
bolognesi
fishing
carter
et
al
lane
et
al
sheridan
et
al
fda
hopkin
pompid
et
al
tuazon
labriola
reconstitut
thu
far
unsuccess
treatment
work
measur
must
develop
prevent
transplant
cell
becom
infect
hiv
success
therapi
aid
may
eventu
reli
upon
combin
immunomodulatori
antivir
approach
prior
identif
hiv
ultrastructur
research
etiolog
aid
yield
number
candid
caus
agent
ident
mani
particl
sinc
elucid
actual
virion
present
opportunist
infect
other
either
subcellular
organel
artifact
still
other
viralinduc
nonspecif
chang
frequent
report
observ
tubuloreticular
structur
tr
tubulorecticular
inclus
trd
see
tucker
pp
seen
mainli
lymphocyt
fereman
et
al
orenstein
schaff
et
al
schenk
et
al
sidhu
et
al
thune
et
al
watanab
et
al
zuckerfranklin
also
choroid
eye
jensen
endotheli
cell
kaposi
sarcoma
fibroblast
zuckerfranklin
wormlik
inclus
resembl
nucleocapsid
myxovirus
though
tr
slightli
larger
diamet
nm
vs
nm
fig
lla
c
similar
structur
describ
kidney
patient
system
lupu
erythematosu
sle
seen
diseas
drugtreat
cell
sinkov
et
al
grimley
et
al
grimley
schaff
schaffet
al
larger
rodlik
structur
measur
x
nm
describ
lymphoid
line
infant
aid
burrag
et
al
tr
contain
lipid
acid
glycoprotein
nucleic
acid
sidhu
waisman
factor
predispos
develop
tr
obscur
antibodi
htlvi
perhap
crossreact
antibodi
identifi
individu
sle
olsen
et
al
rais
possibl
retrovir
infect
patient
provid
plausibl
explan
ultrastructur
similar
aid
sle
tr
also
relat
interferon
exposur
rich
membran
structur
design
test
tube
ringshap
form
trf
cylindr
confront
cisterna
ccc
cylindr
confront
lamella
ccl
seen
mani
aid
patient
fig
llb
c
see
tucker
appear
concentr
arrang
endoplasm
reticulum
alay
electrondens
materi
interpos
may
pm
long
nm
diamet
kostianovski
et
al
sidhu
et
al
similar
inclus
seen
diseas
adult
cell
leukemia
neoplasm
multipl
sclerosi
sle
well
virusinfect
cell
shamoto
et
al
prinea
hammar
et
al
trf
differenti
simpl
pair
cisterna
seen
stimul
cell
kostianovski
et
al
continu
tr
trf
seen
fig
llc
probabl
result
membran
prolifer
perhap
caus
viral
infect
stimul
fereman
et
al
hammar
et
al
kostianovski
et
al
schaff
et
al
anoth
membran
structur
compos
vesicl
within
larger
membran
describ
lymphocyt
aid
patient
fig
lle
fereman
et
al
gardin
et
al
suggest
organel
repres
multivesicular
bodi
mvb
similar
seen
normal
brown
et
al
ghadial
activ
grossi
et
al
lymphocyt
howev
later
public
fereman
et
al
describ
immunolabel
larg
cytoplasm
vacuol
resembl
mvb
mononuclear
cell
aid
patient
antibodi
use
htlvi
bovin
leukemia
viru
follow
secondari
antibodi
conjug
colloid
gold
author
specul
label
materi
consist
h
n
antigen
crossreact
antibodi
core
protein
relat
virus
vesicular
rosett
describ
lymphocyt
aid
patient
bulbou
membran
structur
nm
diamet
contain
vesicl
fig
ewe
et
al
also
seen
situat
miller
fig
viruslik
structur
unusu
ultrastructur
report
aid
patient
tr
nm
diamet
b
trf
compos
rough
endoplasm
reticulum
enclos
dens
materi
cut
longitudin
small
arow
cross
larg
arrow
section
c
trf
tr
lumen
tr
togeth
vacuol
resembl
mvb
e
viruslik
structur
v
insid
cytoplasm
vesicl
structur
resembl
mvb
vesicl
fi
vesicular
rosett
cytoplasm
compos
smaller
vesicl
g
viruslik
particl
phagocytos
debri
within
histiocyt
h
intracytoplasm
particl
n
epitheli
cell
patient
g
extracellular
viruslik
vesicl
tissu
cultur
cell
cocultiv
aid
materi
bar
w
except
inset
g
h
nm
c
reprint
sidhu
et
al
permiss
lancet
b
orenstein
permiss
lancet
e
fereman
et
al
permiss
lancet
f
ewe
et
al
permiss
new
england
journal
medicin
g
h
chandler
et
al
permiss
annal
intern
medicin
lo
permiss
american
journal
tropic
medicin
roger
distinct
multivesicular
bodi
lysozom
question
zuckerfranklin
unidentifi
particl
nm
electrondens
core
report
intestin
epitheli
cell
aid
patient
fig
llg
h
seen
predominantli
within
membranebound
cytoplasm
vacuol
phagocytos
debri
occasion
observ
extracellularli
author
specul
differ
previous
report
breakdown
product
chandler
et
al
viruslik
particl
nm
diamet
enclos
diamet
tubular
structur
resembl
nucleocapsid
fig
lli
seen
intraand
extracytoplasm
mous
cell
line
transfect
dna
patient
aid
nontransfect
cell
lo
structur
resembl
known
virus
singl
publish
micrograph
difficult
distinguish
cell
process
import
understand
viral
process
patient
aid
overemphas
present
time
opportunist
viral
infect
account
larg
portion
morbid
mortal
experienc
patient
tempo
viral
infect
individu
aid
often
swift
demand
rapid
accur
diagnost
approach
therapi
viral
infect
aid
patient
though
current
far
satisfactori
benefit
focu
intens
investig
futur
elucid
pathogenesi
aid
ultim
conquest
diseas
rest
least
part
understand
viral
mechan
anticip
investig
modal
describ
play
major
role
understand
barin
